Elevated C-reactive protein levels in the development of type 1 diabetes.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 15448085)

Published in Diabetes on October 01, 2004

Authors

H Peter Chase1, Sonia Cooper, Iris Osberg, Lars C Stene, Katherine Barriga, Jill Norris, George S Eisenbarth, Marian Rewers

Author Affiliations

1: Department of Pediatrics, The Barbara Davis Center for Childhood Diabetes, Denver, Colorado, USA. peter.chase@uchsc.edu

Associated clinical trials:

Nutritional Intervention to Prevent Diabetes | NCT00333554

Articles by these authors

A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet (2004) 12.25

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A (2007) 6.44

Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med (2014) 5.44

Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature (2005) 5.39

Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA (2003) 4.00

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA (2013) 3.65

Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA (2005) 3.61

Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol (2006) 3.55

A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity (2005) 3.07

Predictors of acute complications in children with type 1 diabetes. JAMA (2002) 3.04

Infant exposures and development of type 1 diabetes mellitus: The Diabetes Autoimmunity Study in the Young (DAISY). JAMA Pediatr (2013) 2.92

Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab (2010) 2.70

Type 1 diabetes: recent developments. BMJ (2004) 2.66

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes (2008) 2.60

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes (2003) 2.51

Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol (2003) 2.51

A prospective study of the incidence of childhood celiac disease. J Pediatr (2003) 2.50

Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation (2005) 2.46

The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes (2011) 2.44

Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth. Diabetes Care (2007) 2.38

Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med (2002) 2.29

IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum Mol Genet (2008) 2.27

Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am J Roentgenol (2004) 2.26

Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab (2004) 2.19

A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes (2008) 2.09

Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA (2007) 2.04

Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis. Pediatr Pulmonol (2005) 2.00

Insulin as an autoantigen in NOD/human diabetes. Curr Opin Immunol (2008) 1.95

Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening. Diabetes (2008) 1.90

Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci U S A (2006) 1.90

Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc Natl Acad Sci U S A (2010) 1.87

Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care (2011) 1.86

Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr (2003) 1.86

Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes (2007) 1.84

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes (2010) 1.80

Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad Sci U S A (2003) 1.75

Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol (2007) 1.75

How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited. Diabetes (2011) 1.74

Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation (2005) 1.72

Dyslipidemia in youth with diabetes: to treat or not to treat? J Pediatr (2008) 1.72

Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes (2010) 1.67

Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care (2004) 1.65

Impact of celiac autoimmunity on children with type 1 diabetes. J Pediatr (2007) 1.64

Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study. Diabetes Care (2013) 1.58

Celiac autoimmunity in children with type 1 diabetes: a two-year follow-up. J Pediatr (2011) 1.57

Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis. Diabetes (2007) 1.56

Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab (2003) 1.55

Distinguishing persistent insulin autoantibodies with differential risk: nonradioactive bivalent proinsulin/insulin autoantibody assay. Diabetes (2011) 1.53

Epidemiology of coeliac disease and comorbidity in Norwegian children. J Pediatr Gastroenterol Nutr (2013) 1.53

Concordance for islet autoimmunity among monozygotic twins. N Engl J Med (2008) 1.53

Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes (2006) 1.49

In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care (2003) 1.49

Persistently autoantibody negative (PAN) type 1 diabetes mellitus in children. Pediatr Diabetes (2010) 1.48

Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study. Acta Diabetol (2014) 1.48

High prevalence of human enterovirus a infections in natural circulation of human enteroviruses. J Clin Microbiol (2006) 1.47

Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab (2006) 1.47

Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant (2010) 1.45

Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care (2012) 1.45

Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes. Diabetes (2007) 1.44

Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J Clin Invest (2007) 1.44

Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care (2005) 1.43

Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care (2003) 1.43

Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY. Diabetes Metab Res Rev (2013) 1.43

Analysis of pathogenesis of juvenile new-onset diabetes. J Diabetes (2011) 1.42

SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann N Y Acad Sci (2008) 1.42

Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes. J Clin Hypertens (Greenwich) (2014) 1.41

Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A (2002) 1.40

Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes (2006) 1.38

Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). Pediatr Diabetes (2006) 1.33

Systematic shifts in cystatin C between 2006 and 2010. Clin J Am Soc Nephrol (2011) 1.32

Asymptomatic circulation of HEV71 in Norway. Virus Res (2006) 1.31

Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes (2006) 1.30

Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr (2007) 1.30

The stages of type 1A diabetes: 2005. Immunol Rev (2005) 1.29

Editorial: Mortality and renal disease in type 1 diabetes mellitus--progress made, more to be done. J Clin Endocrinol Metab (2006) 1.29

Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates. Pediatr Diabetes (2005) 1.28